The result also exhibited the following: epigenetic silencing of CRABP2 protein tremendously promoted tumors demonstrating a lower level of resistance ER+ breast cancer invasion and metastasis; Ectopic expression of CRABP2 also promoted tumors demonstrating a lower level of resistance ER− breast cancer metastasis and invasion. This evidence concerns the gene CRABP2 and breast cancer.